A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This study will assess the effects of strong CYP1A2 (Cytochrome P450 1A2) inhibitor (fluvoxamine) on savolitinib exposure in healthy male subjects, performed at a single clinical unit.
Epistemonikos ID: e5f82ae8ab7227d9a4c54bbd98fcca02f8c4b7c0
First added on: Oct 02, 2023